Error message

  • Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/jscireso/jayumedsci.com/sites/all/modules/biblio/includes/biblio_theme.inc).
  • Deprecated function: Array and string offset access syntax with curly braces is deprecated in require_once() (line 341 of /home/jscireso/jayumedsci.com/includes/module.inc).
  • Deprecated function: Array and string offset access syntax with curly braces is deprecated in require_once() (line 341 of /home/jscireso/jayumedsci.com/includes/module.inc).

Impact of Mercury on the Efficacy of Amavatari Rasa in Rheumatoid Arthritis: A Randomized Double Blind Trial

Article View

Abstract
Journal of Ayurveda Medical Sciences J,2016,1,2,97-103.
Published:October 2016
Type:Original Article
Authors:
Author(s) affiliations:

Sonam S Bhinde1*, Galib R2, Pradeep K Prajapati3

1Lecturer, Manjushri Research Institute of Ayurvedic Sciences, Gandhi Nagar, Gujarat. .

2Associate Professor, 3Professor and Head, Department of Rasa Shastra and Bhaishajya Kalpana, All India Institute of Ayurveda, New Delhi, INDIA 110076.

Abstract:

Introduction: Rheumatoid arthritis (RA) is one of the most challenging diseases due to its chronicity, incurability, complications and morbidity. It is an auto-immune inflammatory disease. From Ayurveda point of view, this disease can be correlated with Amavata in its clinical presentation. In spite of potent anti-inflammatory and powerful immunosuppressive agents; itsprognosis is bad and these drugs are associated with certain side effects too. Ayurveda holds various formulations for this condition and Amavatari Rasa, a mercurial formulation is one among them. Aim of the current study is to evaluate impact of Mercury on the efficacy of Amavatari Rasa in Rheumatoid Arthritis through double blind trial. Methods: Total 86 patients were registered and randomly divided into two groups and were treated with Amavatari Rasa prepared in absence of mercury (ARM) and Amavatari Rasa with mercury (ARC) at dose of 250 mg thrice a day, 30 minutes before meal with luke warm water for 8 weeks. Assessment was done on the basis of clinical recovery, symptomatic relief and pathological investigations. Results: At the end of the trial; the nature of the trial drugs was unveiled.Both the formulations showed highly significant results (p<0.001) in all the signs and symptoms except trishna (thirst). Majority of the signs and symptoms were better relieved with ARM group, whereas biological markers corrected with ARC group. Though, there is no significant difference in between the results of both the groups, ARC appears to be influencing the cellular level of pathology, while ARM is helpful in providing symptomatic relief. Conclusion: Thus, it can be inferred that, presence of mercury is essential that helps in taking the drug to the cellular levels and breaking the pathology successfully. No untoward effects were noticed in any patients during the study period.